|
1
|
Lian J, Zhang H, Wei F, Li Q, Lu Y, Yu B,
Yu L, Liang X, Wen Y, Jin K, et al: Long non-coding RNA DANCR
promotes colorectal tumor growth by binding to lysine
acetyltransferase 6A. Cell Signal. 67:1095022020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang Y, Sun H, Ma X, Zeng Y, Pan Y, Yu D,
Liu Z and Xiang Y: HLA-F-AS1/miR-330-3p/PFN1 axis promotes
colorectal cancer progression. Life Sci. 254:1171802020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20:57582019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Liu G, Ye W, Xie J, Shao C, Wang
X and Li X: ZEB2-AS1 accelerates epithelial/mesenchymal transition
through miR-1205/CRKL pathway in colorectal cancer. Cancer Biother
Radiopharm. 35:153–162. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng Y, Nie P and Xu S: Long noncoding
RNA CASC21 exerts an oncogenic role in colorectal cancer through
regulating miR-7-5p/YAP1 axis. Biomed Pharmacother. 121:1096282020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu F, Jia J, Sun L, Yu Q, Duan H, Jiao D,
Gong Z, Zhu S, Jiang K, He Y, et al: lncRNA DSCAM-AS1 downregulates
miR-216b to promote the migration and invasion of colorectal
adenocarcinoma cells. Onco Targets Ther. 12:6789–6795. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Ma S, Lin T, Li Y, Yang S, Zhang W,
Zhang R and Wang Y: Comprehensive analysis of therapy-related
messenger RNAs and long noncoding RNAs as novel biomarkers for
advanced colorectal cancer. Front Genet. 10:8032019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun W, Ren S, Li R, Zhang Q and Song H:
LncRNA, a novel target biomolecule, is involved in the progression
of colorectal cancer. Am J Cancer Res. 9:2515–2530. 2019.PubMed/NCBI
|
|
9
|
Bermúdez M, Aguilar-Medina M,
Lizárraga-Verdugo E, Avendaño-Félix M, Silva-Benítez E,
López-Camarillo C and Ramos-Payán R: LncRNAs as regulators of
autophagy and drug resistance in colorectal cancer. Front Oncol.
9:10082019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amirkhah R, Naderi-Meshkin H, Shah JS,
Dunne PD and Schmitz U: The intricate interplay between epigenetic
events, alternative splicing and noncoding RNA deregulation in
colorectal cancer. Cells. 8:9292019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang C, Zhao T, Li H, He F, Zhao X, Zhang
Y, Chu X, Hua C, Qu Y, Duan Y, et al: Long non-coding RNA ITIH4-AS1
accelerates the proliferation and metastasis of colorectal cancer
by activating JAK/STAT3 signaling. Mol Ther Nucleic Acids.
18:183–193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan Y, Sheng W, Meng Y, Cao Y and Li R:
LncRNA PTENP1 inhibits cervical cancer progression by suppressing
miR-106b. Artif Cells Nanomed Biotechnol. 48:393–407. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yue X, Wu WY, Dong M and Guo M: LncRNA
MALAT1 promotes breast cancer progression and doxorubicin
resistance via regulating miR-570-3p. Biomed J.
43:4982020.PubMed/NCBI
|
|
14
|
Ouyang J, Liu Z, Yuan X, Long C, Chen X,
Wang Y, Liu L, Liu S and Liang H: LncRNA PRNCR1 promotes breast
cancer proliferation and inhibits apoptosis by modulating
microRNA-377/CCND2/MEK/MAPK axis. Arch Med Res. 52:471–482. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ping G, Xiong W, Zhang L, Li Y, Zhang Y
and Zhao Y: Silencing long noncoding RNA PVT1 inhibits
tumorigenesis and cisplatin resistance of colorectal cancer. Am J
Transl Res. 10:138–149. 2018.PubMed/NCBI
|
|
16
|
Yu X, Zhao J and He Y: Long non-coding RNA
PVT1 functions as an oncogene in human colon cancer through
miR-30d-5p/RUNX2 axis. J BUON. 23:48–54. 2018.PubMed/NCBI
|
|
17
|
Zhang R, Li J, Yan X, Jin K, Li W, Liu X,
Zhao J, Shang W and Liu Y: Long noncoding RNA plasmacytoma variant
translocation 1 (PVT1) promotes colon cancer progression via
endogenous sponging miR-26b. Med Sci Monit. 24:8685–8692. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Xiao J, Lu X, Liu T, Jin X, Xiao
Y and He X: PVT1 (rs13281615) and miR-146a (rs2910164)
polymorphisms affect the prognosis of colon cancer by regulating
COX2 expression and cell apoptosis. J Cell Physiol.
234:17538–17548. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Huang S, Li Y, Zhang W, He K, Zhao
M, Lin H, Li D, Zhang H, Zheng Z and Huang C: Decreased expression
of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and
EMT in colorectal cancer cells. Tumour Biol. 37:14205–14215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang F, Ni H, Sun F, Li M and Chen L:
Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis
and promotes tumorigenesis in colorectal cancer. Biomed
Pharmacother. 81:152–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lei Y, Jing-Jing L, Ke-Nan Z, Qing-Zhong T
and Jin L: A tumor suppressive role of lncRNA GAS5 in human
colorectal cancer. Open Life Sci. 11:105–109. 2016. View Article : Google Scholar
|
|
23
|
Wang Y, Chen W, Lian J, Zhang H, Yu B,
Zhang M, Wei F, Wu J, Jiang J, Jia Y, et al: The lncRNA PVT1
regulates nasopharyngeal carcinoma cell proliferation via
activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell
Death Differ. 27:695–710. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan H, Zhu JH and Yao XQ: Knockdown of
long non-coding RNA PVT1 reverses multidrug resistance in
colorectal cancer cells. Mol Med Rep. 17:8309–8315. 2018.PubMed/NCBI
|
|
25
|
Gharib E, Anaraki F, Baghdar K, Ghavidel
P, Sadeghi H, Nasrabadi PN, Peyravian N, Aghdaei HA, Zali MR and
Mojarad EN: Investigating the diagnostic performance of HOTTIP,
PVT1, and UCA1 long noncoding RNAs as a predictive panel for the
screening of colorectal cancer patients with lymph node metastasis.
J Cell Biochem. 120:14780–14790. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Zhang S, Yin J and Xu R: MiR-566
mediates cell migration and invasion in colon cancer cells by
direct targeting of PSKH1. Cancer Cell Int. 19:3332019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan L, Zhang Y, Li K, Wang M, Li J, Qi Z,
Wu J, Wang Z, Ling L, Liu H, et al: miR-593-5p inhibit cell
proliferation by targeting PLK1 in non small cell lung cancer
cells. Pathol Res Pract. 216:1527862020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mou TY, Zhang RR and Wang YN: MiRNA-212
acts as a tumor-suppressor in colorectal carcinoma through
targeting SOX4. Eur Rev Med Pharmacol Sci. 23:10751–10760.
2019.PubMed/NCBI
|
|
29
|
Zhang D, Li Y and Sun P: miR-770-5p
modulates resistance to methotrexate in human colorectal
adenocarcinoma cells by downregulating HIPK1. Exp Ther Med.
19:339–346. 2020.PubMed/NCBI
|
|
30
|
Zhao Q, Liu C, Cui Q, Luan X, Wang Q and
Zhou C: miR-190b promotes colorectal cancer progression through
targeting forkhead box protein P2. Exp Ther Med. 19:79–84.
2020.PubMed/NCBI
|
|
31
|
Li H, Zhu G, Xing Y, Zhu Y and Piao D:
miR-4324 functions as a tumor suppressor in colorectal cancer by
targeting HOXB2. J Int Med Res. Dec 18–2019.(Epub ahead of print).
doi: 10.1177/0300060519883731.
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang M, Zheng S, Li X, Ding Y, Zhang M,
Lin L, Xu H, Cheng Y, Zhang X, Xu H and Li S: Integrated analysis
of lncRNA-miRNA-mRNA ceRNA network identified lncRNA EPB41L4A-AS1
as a potential biomarker in non-small cell lung cancer. Front
Genet. 11:5116762020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xue C, Zhang X, Gao P, Cui X, Zhu C and
Qin X: LncRNA loc339803 acts as CeRNA of miR-30a-5p to promote the
migration and invasion of hepatocellular carcinoma cells. J Cancer.
12:1061–1072. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ni X, Xie JK, Wang H and Song HR:
Knockdown of long non-coding RNA LINC00324 inhibits proliferation,
migration and invasion of colorectal cancer cell via targeting
miR-214-3p. Eur Rev Med Pharmacol Sci. 23:10740–10750.
2019.PubMed/NCBI
|
|
36
|
Wu H, Wei M, Jiang X, Tan J, Xu W, Fan X,
Zhang R, Ding C, Zhao F, Shao X, et al: lncRNA PVT1 promotes
tumorigenesis of colorectal cancer by stabilizing miR-16-5p and
interacting with the VEGFA/VEGFR1/AKT axis. Mol Ther Nucleic Acids.
20:438–450. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu F, Wu R, Guan L and Tang X: Knockdown
of PVT1 suppresses colorectal cancer progression by regulating
MiR-106b-5p/FJX1 axis. Cancer Manag Res. 12:8773–8785. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li S, Wu T, Zhang D, Sun X and Zhang X:
The long non-coding RNA HCG18 promotes the growth and invasion of
colorectal cancer cells through sponging miR-1271 and upregulating
MTDH/Wnt/β-catenin. Clin Exp Pharmacol Physiol. 47:703–712. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang QQ, Chen CY, Chen Z and Chang S:
LncRNA PVT1 promotes proliferation and invasion through enhancing
Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol
Oncol. 53:443–452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiong X, Yuan J, Zhang N, Zheng Y, Liu J
and Yang M: Silencing of lncRNA PVT1 by miR-214 inhibits the
oncogenic GDF15 signaling and suppresses hepatocarcinogenesis.
Biochem Biophys Res Commun. 521:478–484. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zeng X, Liu Y, Zhu H, Chen D and Hu W:
Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses
colorectal cancer progression via modulation of YBX1 expression.
Cancer Manag Res. 11:6981–6993. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aravindan N, Subramanian K, Somasundaram
DB, Herman TS and Aravindan S: MicroRNAs in neuroblastoma
tumorigenesis, therapy resistance, and disease evolution. Cancer
Drug Resist. 2:1086–1105. 2019.PubMed/NCBI
|
|
43
|
Ren Y, Shi G, Jiang P and Meng Q:
MicroRNA-761 is downregulated in colorectal cancer and regulates
tumor progression by targeting Rab3D. Exp Ther Med. 17:1841–1846.
2019.PubMed/NCBI
|
|
44
|
Cao S, Lin L, Xia X and Wu H: MicroRNA-761
promotes the sensitivity of colorectal cancer cells to
5-fluorouracil through targeting FOXM1. Oncotarget. 9:321–331.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Xiao T and Zhao M: MicroRNA-675
directly targets MAPK1 to suppress the oncogenicity of papillary
thyroid cancer and is sponged by long non-coding RNA RMRP. Onco
Targets Ther. 12:7307–7321. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhu L, Yang S and Wang J: miR-217 inhibits
the migration and invasion of HeLa cells through modulating MAPK1.
Int J Mol Med. 44:1824–1832. 2019.PubMed/NCBI
|
|
47
|
Zabihula B, Yiliyasi M, Lu Y and Salai A:
MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of
ESCC cells via MAPK1 downregulation. Oncol Lett. 18:3170–3176.
2019.PubMed/NCBI
|
|
48
|
Anand V, Khandelwal M, Appunni S, Gupta N,
Seth A, Singh P, Mathur S and Sharma A: CD44 splice variant
(CD44v3) promotes progression of urothelial carcinoma of bladder
through Akt/ERK/STAT3 pathways: Novel therapeutic approach. J
Cancer Res Clin Oncol. 145:2649–2661. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wei WT, Nian XX, Wang SY, Jiao HL, Wang
YX, Xiao ZY, Yang RW, Ding YQ, Ye YP and Liao WT: miR-422a inhibits
cell proliferation in colorectal cancer by targeting AKT1 and
MAPK1. Cancer Cell Int. 17:912017. View Article : Google Scholar : PubMed/NCBI
|
